March 13, 1997

Dolly: Clone or Commodity?

RAFI Follows the Money

Before disclosing the cloning breakthrough, patent applications were filed and research papers prepared for publication. PPL Therapeutics, a small biotechnology company will be assigned the patent. After the cloning announcement, shares of PPL Therapeutics jumped 16% in one day on the London Stock Exchange.

PDF icon Download File0 bytes

Please consider supporting ETC's unique research and advocacy with a tax-deductible donation. Donate here